Skip to main content

Evaluation of diagnostic criteria for IgG4-related tubulointerstitial nephritis



IgG4-TIN is the most common pattern of renal involvement in IgG4-related disease. There are several proposed diagnostic criteria of IgG4-TIN recently. Two of them proposed by the Mayo Clinic and JSN are predominant. However, histopathological criteria of the number of IgG4+ plasma cells and several histological features are still under discussion due to low amount of tissue in renal biopsy specimens and low frequency of this kind of specimens. We aimed to screen IgG4-TIN on archived renal biopsy samples and evaluated the application of two proposed diagnostic criteria.


We selected 480 interstitial inflammation samples for light and electron microscopy and immunohistochemistry of CD138, IgG and IgG4 test. The Mayo Clinic proposed criteria diagnosed high-probability IgG4-TIN and JSN criteria confirmed IgG4-TIN.


Twelve high-probability IgG4-TIN were screened by histology, imaging, serology and other organ involvement according to the Mayo Clinic proposed criteria. The previous principal pathological diagnoses were IgAN (n=4), CreGN (n=4), tubulointerstitial nephritis (n=3) and LN (n=1). Three cases showed storiform fibrosis and a bird’s eye pattern. The distribution of IgG4+ plasma cells was focal, multifocal or diffuse, with a mixed mild, moderate or strong stainingpattern. Their treatment and clinical outcomes varied depending on different levels of proteinuria, serum creatinine, eGFR and original glomerular disease presentation. Therefore, we applied strict histological criteria of storiform fibrosis and evenly distributed IgG4+ plasma cells by JSN to confirm typical IgG4-TIN. Two cases were finally diagnosed as real IgG4-TIN. One was previously diagnosed as idiopathic interstitial nephritis with rapid response to corticosteroid therapy. The other was CreGN with immune complex deposits, which had poor outcome and long-term hemodialysis.


IgG4-TIN might present concurrently with glomerular disease. The proposed criteria by the Mayo Clinic is flexible, sensitive, and superior in the identification of early-stage or atypical IgG4-TIN, with enhanced risk of misdiagnosis as compared to the proposed criteria by JSN, which is stricter, more specific, and might overlook early-stage or atypical IgG4-TIN. We propose a new set of criteria to improve pathologist-derived diagnosis.


IgG4-RD is recognized as a systemic autoimmune disease that is characterized by significant lymphoplasmacytic infiltration of IgG4 positive plasma cells, with obliterative phlebitis and storiform fibrosis leading to organ swelling or nodular lesions [13]. It was first recognized as sclerosing or AIP, which usually occurs with multi-organ involvement. Single organ injury such as kidney damage was reported occasionally [26]. IgG4-TIN was the most common pattern of renal involvement [711]. There were several proposed diagnostic criteria of IgG4-TIN in recent years, most of which emphasized histological features and rich IgG4+ plasma cells as indispensable criteria [3, 11, 12]. Nevertheless, the suitable cut-off values of IgG4+ plasma cells and the diagnostic strength of other specific histopathologic features are still debated in literature, also due to low amount of tissue in renal biopsy specimens and low frequency of this kind of specimens. In addition, IgG4 analysis in renal biopsy was not routinely performed previously, thus IgG4-TIN awareness was suffered and it would be easily misdiagnosed, especially when the morphological appearance was atypical. In this study, we retrospectively screened IgG4-TIN from archived renal biopsy samples, analyzed their clinical pathological characteristics and evaluated the utility of two proposed diagnostic criteria to identify their potential advantages and disadvantages.

Materials and Methods

Patients’ selection

Patients with sufficient acute or chronic interstitial inflammation (the frequency of inflammatory cells that were > 25 % within the cortical interstitium) by light microscopy were enrolled in this study from April 2008 through December 2013, irrespective of the presence or absence of glomerular disease. Altogether, 480 patients who were first admitted as renal injury without any remarkable medical history were studied following approval by the ethical committees of Hangzhou Hospital of Traditional Chinese Medicine.

HE-stained slides were reviewed by two pathologists. Cases were selected by lightmicroscopy as having an average plasma cell count of more than 5 plasma cells in at least 3 HPF fields [12]. Sections from the corresponding paraffin-embedded tissue blocks were recut and immunostained for the following antibodies: CD138 (#IR642; 1:50; Dako Cytomation, Glostrup, Denmark), IgG (#A0423; 1:250; Dako Cytomation, Glostrup, Denmark) and IgG4 (#AU009; 1:500; Binding Site, Birmingham, UK). Antigen was retrieved by EDTA solution as well as gastric enzyme, and Elivision system was applied in IHC detection. The positive cell counting was calculated as an average number per HPF over three fields. Abundant plasma cells were defined as more than 20/HPF. Suspected IgG4-TIN were defined as IgG4 positive cells > 10/HPF or IgG4/IgG positive cells >40 %.

Screening for high-probability IgG4-TIN

High-probability IgG4-TIN cases were screened according to the criteria proposed by the Mayo Clinic as shown in Table 1 [12]. Clinical and laboratory features including age, gender, microscopic hematuria (−, <3; ±, 3–10; + 11–20; 2+, 21–40; 3+, 41–100; 4+, >100), 24-hour proteinuria, albumin, SCr, eGFR and IgG levels were then analyzed. The presence of eGFR was calculated by the mordification of diet in renal disease (MDRD). Histological features, determined on the basis of previous pathological studies of IgG4-RD were reanalyzed [3, 9, 1317]. Immune complex deposits in TBM were observed by IgG test and electron microscopy.

Table 1 Two proposed criteria for IgG4-TIN by the Mayo Clinic and JSN

Confirmation of IgG4-TIN

The histological criterion proposed by JSN was much stricter as shown in Table 1 [18]. It emphasized that storiform fibrosis was an essential criterion, and that IgG4 positive cells should be marked and densely stained [18, 19]. We followed this guideline to confirm IgG4-TIN since lesions were numerous in our study, including many different glomerular diseases that might lead to a misdiagnosis of the underlying condition. Therefore confirmed IgG4-TIN was screened from a high-probability IgG4-TIN group according to the criteria proposed by JSN.

Statistical analysis

Statistical analysis was performed with SPSS software version 17.0. Normally distributed data were expressed as mean ± SD. The clinical characteristics between two groups were compared by Student’s t test. Categorical variables of histological features between two groups were expressed as percentages and were compared by Chi-square test or Fisher’s exact test. Correlations were assessed by Spearman’s rank correlation to estimate the relationship of the clinical characteristics associated with IgG4 positive cells and the stage of interstitial fibrosis. P-values less than 0.05 were considered statistically significant.


Cases of suspected IgG4-TIN

The procedure of screening cases is shown in Fig. 1. Herein, 480 samples with sufficient interstitial inflammation that accounted for 24.2 % of total renal biopsy specimens were selected in our study. After re-observing these specimens by light microscopy, 55 cases demonstrating abundant plasma cells were screened. Furthermore, 21 cases of suspected IgG4-TIN were screened from the previous group by CD138, IgG and IgG4 test, which accounted for 38.2 % of abundant plasma cell cases and 4.4 % of sufficient inflammation cases. The average number of CD138, IgG and IgG4 positive cells were 75.8 ± 34.9, 34.0 ± 21.3 and 19.9 ± 13.3 respectively. Their predominant pathological diagnoses were IgAN, CreGN and TIN respectively, whilst others were FSGS, LN, MN and SS.

Fig. 1

The procedure of screening cases

Cases of high-probability IgG4-TIN

According to the proposed criteria of the Mayo Clinic [12], twelve cases were screened at least for one other feature from the imaging, serology, or other organ involvement, which accounted for 57.1 % of suspected cases of IgG4-TIN. The average age was 52 years (range, 30 to 76 years). Six cases were male and the other six were female. Patients were much older (p < 0.01) whereas the incidence of proteinuria was lower (p < 0.05) than that of excluded cases (please see Table 2). In addition, Table 3 showed clinical and pathological features of twelve cases. Ten cases (or 83.3 %) had increased serum IgG levels; three cases (or 25 %) showed diffuse enlargement of both kidneys, six cases (or 50 %) presented with pulmonary interstitial fibrosis and one case had lymph node enlargement. All but one of the cases manifested acute (n = 6) or chronic (n = 5) renal failure.

Table 2 The comparison of clinical characteristics between the high-probability IgG4-TIN group and excluded group in abundant plasma cells samples
Table 3 Clinical, radiographic, laboratory and pathological features of twelve high-probability IgG4-TIN cases

Originally, nine cases were diagnosed with glomerular diseases and three cases were diagnosed with TIN pathologically. Both CreGN and IgAN were predominant glomerular diseases among them. The others were idiopathic TIN, drug-induced TIN and LN (Table 3). Most of their histological features were non-specific; however, storiform fibrosis and a bird’s eye pattern were significantly more frequent than that in the excluded cases (p < 0.01; Table 4). Moreover, IgG4+ plasma cells were focal, multi-focal or evenly distributed, with mild, moderate or strongly stained mixed expression patterns (Fig. 2). Fibrosis was mild or moderate with multifocal distribution. The stage of interstitial fibrosis ranged from 0 to 2, and most cases were in stage 1. It was neither significantly correlated with the number of IgG4+ cells (r = 0.433, P = 0.160) nor TBM immune complex deposits (r = 0.426, P = 0.167). Both the number of IgG4 positive cells and the stage of interstitial fibrosis had no significant correlation with clinical laboratorial characteristics (age, hematuria, proteinuria, albumin, SCr and eGFR) (P > 0.05). Tubulitis presented with significant differences between both groups, though it was not included into specific features of IgG4-TIN (p < 0.05; Table 4). Moreover, IgG or electron dense deposits in TBM were more frequently observed in the high-probability cases than excluded cases (p < 0.05; Table 4).

Table 4 Pathological features of confirmed IgG4-TIN, high-probability IgG4-TIN and both excluded groups in abundant plasma cells samples
Fig. 2

Histological features and immunohistochemistry findings of case twelve. a) Multi-focal fibrosis with obliteration of several tubules (×40) HE. b) Isolated glomeruli in the middle of fibrosis (×100) PAM. c) IgA deposits in mesengium (×200) IF. d) Multi-focally distributed plasma cells by CD138 test (×100) IHC. e) Focally scattered IgG4 positive cells by IgG4 test (×100) IHC. f) IgG4 test (×200) IHC

Cases of confirmed IgG4-TIN

In the high-probability IgG4-TIN group, all 12 cases presented with substantial histological differences, including the stage of fibrosis, the number of IgG4 positive cells and their distribution. Their treatment and clinical outcomes were absolutely different, and were dependent, at least in part, on proteinuria, serum creatinine, eGFR and presence of original glomerular disease. Therefore, we applied strict morphological criterion by JSN to confirm the diagnosis of IgG4-TIN and found three cases that met it. Two cases (case 5 and case 11) met all criteria of histology, imaging, serology and other organ involvement. The left case (case 10) met all criteria but the imaging criterion.. The histological feature of this case, such as storiform fibrosis, was mild and distributed focally. Moreover, IgG4 positive cells were unevenly distributed and moderately stained. Therefore, we checked through the finding of more references, in which it was recommended to identify the presence of dense, diffuse infiltrates of IgG4 positive cells >50/HPF, which were highly specific [2024]. Moreover, an immunohistochemical study of IgG4-TIN from JSN showed the average number of IgG4 positive cells was 43.8/HPF [5]. Besides, Houghton DC and Troxell ML presented that the distribution of IgG4 positive cells were even and uniform in IgG4-TIN, while they were focal or multi-focal in various settings of interstitial nephritis [17]. Finally, we put the remained one case in the high-probability IgG4-TIN group, from which two cases were finally confirmed as IgG4-TIN. One of IgG4-TIN manifested ARF and the principal pathological diagnosis was immune complex CreGN. His serum ANCA was negative, which had no proof of AAV. The serum IgG4 level had decreased rapidly after a large dose of corticosteroid treatment, whereas his serum creatinine hardly decreased and hemodialysis was finally applied. Another case displayed chronic renal failure and the previous diagnosis was idiopathic TIN. Serum IgG4 level was undetectable at this time. Large dose of corticosteroids was prescribed and serum creatinine had decreased to normal level by one half month later. Both cases presented with a diffuse bird’s-eye pattern and focal storiform features [25] (Fig. 3), whereas there was only one case that showed specific fibrosis in ten left cases, which had significant difference (P < 0.01; Table 4). Moreover, IgG4+ plasma cells were presented at a frequency of more than 50 per HPF, which appeared as an evenly strong staining pattern with diffuse infiltration of the renal interstitium, while it was multifocal in left cases. No tubular necrosis was observed in confirmed cases, though it was frequently shown in the left cases.

Fig. 3

Pathological features of case five of histology, IHC and electron microscopy. a) Diffuse fibrosis with obliteration of most tubules and isolation of glomeruli (×40) HE. b) Typical storiform fibrosis with abundant inflammation cells (×200) PAM. c) Rich collagen fibrosis and characteristic bird’s-eye pattern (×200) Masson trichrome staining. d) Characteristic bird’s-eye pattern (×400) PAM. e) Abundant, evenly distributed, strong positive plasma cells in interstitium by CD138 test (×100) IHC. f) Abundant strong stained and evenly distributed IgG4+ plasma cells (>50 per HPF) in interstitium and tubular epithelial cells by IgG4 test (×200) IHC. g) Apparent TBM deposition of two tubules by IgG test (×200) IHC. h) Thickened TBM with scattered electron dense immune complex deposits (×4000) EM


The epidemiology and etiology of IgG4-TIN remain unclear. It has been hypothesized that autoimmune disorders and allergic reactions might be the heterogeneous causes [2628]. However, this was opposed by several researchers. They demonstrated that IgG4 antibody inhibited activation of complement to suppress immune reactivity. Moreover, a specific allergen was never detected [29, 30]. Recently, it was reported that IgG4-TIN was associated with a hematological disorder [31]. Thus, the pathogenesis of this disease remains unclear.

The characteristic histological features such as storiform fibrosis and a bird’s-eye pattern were shown in more than 90 % of IgG4-TIN cases by JSN [18, 32]. By contrast, these presentations were shown in only 17.1 % of cases in the Mayo Clinic [12]. Therefore, several studies tried to define the stages of fibrosis to achieve consensus [19]. In our study, most of the high-probability IgG4-TIN cases showed that mild or moderate fibrosis and the typical storiform pattern was rarely observed. However, a bird’s-eye pattern was easier to find with numerous plasma cell nests encircled in fibrosis [25]. We presumed that this was an early characteristic feature of IgG4-TIN, which would progress to storiform fibrosis. In addition, immune complex deposition in TBM was reported to be more easily observed than specific fibrosis [12, 19]. In the present study, immune complex deposition was marginally more frequently observed than specific fibrosis in the high-probability IgG4-TIN group, although they all presented in the confirmed group. Some common features, such as extension of lesions into renal capsules and eosinophil infiltration strongly indicated IgG4-TIN; while tubulitis, peritubular capillaritis, necrotizing angiitis and neutrophil infiltration were negatively suggestive of IgG4-TIN [19, 25]. However, we found that only tubulitis was more frequent in high-probability IgG4-TIN than that in the excluded cases. Eosinophil infiltration was demonstrated to reproducibly be seen in IgG4-TIN [12, 13, 19], although it was not significantly different from other TIN cases such as allergic interstitial nephritis or acute CreGN in our study. This might be explained by that the lesions seen in our cases were much more variable, including many glomerular diseases with acute interstitial inflammation, thus both eosinophil and neutrophil infiltration were non-specific.

The clinical and pathological evidence of unconfirmed IgG4-TIN remain understudy. It’s unknown whether IgG4-TIN is concurrent with or earlier than glomerular lesions, or the second injury of glomerular diseases. In previous studies, some pauci-immune CreGN, DN, LN and MN met the criteria of IgG4 > 10 per HPF, but they were not real IgG4-TIN [12, 17]. The fibrosis and inflammatory lesions of these suspected cases were patchy or segregated, and IgG4+ plasma cells were focally and less densely distributed, which was different from the IgG4-TIN. In our study, cases were selected irrespective of glomerular disease, thus glomerular nephritis with interstitial IgG4 positive cells was included in high-probability IgG4-TIN, but their histological features had remarkable differences. Moreover, their reaction to treatment and prognosis varied considerably from each other. Six cases recovered well from poor renal function, two cases remained stable, and four cases progressed to end stage renal disease requiring long-term hemodialysis. Therefore we used the stricter criteria proposed by JSN and finally confirmed two cases. One had acute glomerular nephritis, which convinced us to believe that IgG4-TIN could co-exist with glomerulonephritis, wherein the prognosis was much worse and the patient depended on long-term hemodialysis. Although ten left high-probability cases met the proposed criteria by the Mayo Clinic, their clinical manifestations, histological features, treatment and prognosis varied from each other. Thus, we currently consider them to be unreal IgG4-TIN, although frequent follow-up will be necessary to verify. The proposed criteria by the Mayo Clinic are much looser and more sensitive, which makes it easier to determine early-stage or atypical IgG4-TIN, although it increases the risk of misdiagnosis. By contrast, the proposed criteria by JSN are much stricter and more specific, and yet early-stage or atypical IgG4-TIN might be easily missed. Therefore, we propose a new set of criteria for renal biopsy patients in Fig. 4, which would enable the pathologist to make more accurate diagnosis. Further, studies of more accumulated cases and long-term follow-up are necessary for etiology and proposing criteria of atypical IgG4-TIN.

Fig. 4

A new set of criteria of IgG4-TIN for pathologist


IgG4-TIN is easily missed without IgG4 test at the time of renal biopsy. The essential nature of increased IgG4 plasma cells is unclear and it will exist in various kidney diseases meanwhile. Strict histological criteria are helpful, and sometimes necessary in differentiation of IgG4-TIN.



IgG4-related disease


Autoimmune pancreatitis


IgG4-related tubulointerstitial nephritis


Hematoxylin and eosin


High power field




Serum creatinine


Estimated glomerular filtration rate


Tubular basement membrane


The Japanese Society of Nephrology


IgA nephropathy, CreGN, Crescentic glomerulonephritis


Tubulointerstitial nephritis


Focal segmental glomerulous sclerosis


lupus nephritis


Membranous nephropathy


Sjogren Syndrome


Acute renal failure


Antineutrophil cytoplastic antibody


Periodic acid methenaming silver stain




ANCA-associated vasculitis


  1. 1.

    Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol. 2008;14(25):3948–55.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  2. 2.

    Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68(8):1310–5.

    CAS  PubMed  Article  Google Scholar 

  3. 3.

    Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181–92.

    PubMed  Article  Google Scholar 

  4. 4.

    Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344(10):732–8.

    CAS  PubMed  Article  Google Scholar 

  5. 5.

    Takeda S, Haratake J, Kasai T, Takaeda C, Takazakura E. IgG4-associated idiopathic tubulointerstitial nephritis complicating auto-immune pancreatitis. Nephrol Dial Transplant. 2004;19(2):474–6.

    PubMed  Article  Google Scholar 

  6. 6.

    Uchiyama-Tanaka Y, Mori Y, Kimura T, Sonomura K, Umemura S, Kishimoto N, et al. Acute tubulointerstitial nephritis associated with auto-immune-related pancreatitis. Am J Kidney Dis. 2004;43(3):18–25.

    Article  Google Scholar 

  7. 7.

    Saeki T, Nishi S, Ito T, Yamazaki H, Miyamura S, Emura I, et al. Renal lesions in IgG4-related systemic disease. Intern Med. 2007;46(17):1365–71.

    PubMed  Article  Google Scholar 

  8. 8.

    Tsubata Y, Akiyama F, Oya T, Ajiro J, Saeki T, Nishi S, et al. IgG4-related chronic tubulointerstitial nephritis without auto-immune pancreatitis and the time course of renal function. Intern Med. 2010;49(15):1593–98.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, et al. Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78(10):1016–23.

    CAS  PubMed  Article  Google Scholar 

  10. 10.

    He TM, Qu LJ, Xie FL, Zheng ZY. Pathologic features of IgG4 related diseases involving kidney and lymph node. J Diag Pathol. 2013;20(6):340–3.

    Google Scholar 

  11. 11.

    Zheng K, Li XM, Cai JF, Wen YB. Analysis on urinary system lesions of IgG4-related disease. Chin J Nephrol. 2012;28(12):937–42.

    CAS  Google Scholar 

  12. 12.

    Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, et al. Diagnosis of IgG4-Related Tubulointerstitial Nephritis. J Am Soc Nephrol. 2011;22(7):1343–52.

    PubMed Central  PubMed  Article  Google Scholar 

  13. 13.

    Cornell LD. IgG4-related kidney disease. Semin Diagn Pathol. 2012;29(4):245–50.

    PubMed  Article  Google Scholar 

  14. 14.

    Chari ST, Kloeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas. 2010;39(5):549–54.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Cheuk W, Chan JK. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol. 2010;17(5):303–32.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Zen Y, Nakanuma Y. IgG4-related disease. A cross-sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812–9.

    PubMed  Article  Google Scholar 

  17. 17.

    Houghton DC, Troxell ML. An abundance of IgG4+ plasma cells is not specific for IgG4-related tubulointerstitial nephritis. Mod Pathol. 2011;24(11):1480–7. PMID: 21701536

    CAS  PubMed  Article  Google Scholar 

  18. 18.

    Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15(5):615–26.

    PubMed  Article  Google Scholar 

  19. 19.

    Yoshita K, Kawano M, Mizushima I, Colvin RB, Smyrk TC, Takahashi N, et al. Light-microscopic characteristics of IgG4-related tubulointerstitial nephritis: distinction from non-IgG4-related tubulointerstitial nephritis. Nephrol Dial Transplant. 2012;27(7):2755–61.

    PubMed  Article  Google Scholar 

  20. 20.

    Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol. 2007;20(1):23-8.

    CAS  PubMed  Article  Google Scholar 

  21. 21.

    Shrestha B, Sekiguchi H, Colby TV, Graziano P, Aubry MC, Smyrk TC, et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol. 2009;33(10):1450–62.

    PubMed  Article  Google Scholar 

  22. 22.

    Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38(10):982–4.

    CAS  PubMed  Article  Google Scholar 

  23. 23.

    Dhall D, Suriawinata AA, Tang LH, Shia J, Klimstra DS. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis. Hum Pathol. 2010;41(5):643–52.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Kawano M, Mizushima I, Yamaguchi Y, Imai N, Nakashima H, Nishi S, et al. Immunohistochemical Characteristics of IgG4-Related Tubulointerstitial Nephritis: Detailed Analysis of 20 Japanese Cases. Int J Rheumatol. 2012. doi:10.1155/2012/609795.

    Google Scholar 

  25. 25.

    Yamaguchi Y, Kanetsuna Y, Honda K, Yamanaka N, Kawano M, Nagata M, et al. Characteristic tubulointerstitial nephritis in IgG4-related disease. Hum Pathol. 2012;43(4):536–49.

    PubMed  Article  Google Scholar 

  26. 26.

    Cornell LD. IgG4-related tubulointerstitial nephritis. Kidney Int. 2010;78(10):951–3.

    CAS  PubMed  Article  Google Scholar 

  27. 27.

    Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22(1):1–14.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  28. 28.

    Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539–51.

    CAS  PubMed  Article  Google Scholar 

  29. 29.

    Van der Zee JS, van Swieten P, Aalberse RC. Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J Immunol. 1986;137(11):3566–71.

    PubMed  Google Scholar 

  30. 30.

    Nishi S, Imai N, Yoshida K, Ito Y, Saeki T. Clinicopathological findings of immunoglobulin IgG4-related kidney disease. Clin Exp Nephrol. 2011;15(6):810–9.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Malone AF, Sparks MA, Howell DN, Middleton JP, Smith SR, Lehrich RW. IgG4-related tubulointerstitial nephritis associated with chronic lymphocytic leukemia. J Nephrol. 2013;26(6):1195–8.

    PubMed  Article  Google Scholar 

  32. 32.

    Kawano M, Saeki T. IgG4-related kidney disease–an update. Curr Opin Nephrol Hypertens. 2015;24(2):193–201.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

Download references


This study was partially supported by the following: (1) Zhejiang medical and health science and technology plan project (2011KYB081); (2) The clinical speciality and special disease project of Hangzhou Science and Technology bureau (20100733Q29); (3) The national natural science foundation of China (81173426). Those funding sources had no involvement in the study design or data collection. We thank Min Man and Zheng Jie who kindly provided technical support, and Du Xin (Department of Nephrology, Nanjing First Hospital, Nanjing Medical University) for providing excellent English proofreading. We confirm that this article has not been simultaneously reviewed or published elsewhere.

Author information



Corresponding author

Correspondence to Hongyu Chen.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

TXL; participated in staining slides, statistical analysis and writing the article. ZB; participated in designing study, clinical data collecting and article revise. CRP; participated in doing electron microscopy. HYQ; participated in diagnosis of IgG4-TIN. ZYH; participated in laboratory data collecting and analysis. ZXL; participated in providing intellectual content and ethical consent. CHY; participated in designing study and final approval of submission. WYJ; participated in management of members of the study. All authors read and approved the final manuscript.

Xuanli Tang and Hongyu Chen contributed equally to this work.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit

The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tang, X., Zhu, B., Chen, R. et al. Evaluation of diagnostic criteria for IgG4-related tubulointerstitial nephritis. Diagn Pathol 10, 83 (2015).

Download citation


  • Diagnostic criteria
  • IgG4-related tubulointerstitial nephritis
  • IgG4
  • Pathological features
  • Immunohistochemistry